Neogenomics, Inc.
NEO
$6.45
-$0.155-2.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.70% | 10.10% | 11.65% | 12.06% | 13.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.70% | 10.10% | 11.65% | 12.06% | 13.89% |
| Cost of Revenue | 7.37% | 5.37% | 6.75% | 6.67% | 8.81% |
| Gross Profit | 12.83% | 16.70% | 18.60% | 19.92% | 21.52% |
| SG&A Expenses | 7.76% | 6.34% | 7.57% | 4.33% | 2.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.23% | 6.48% | 7.42% | 5.83% | 5.56% |
| Operating Income | 2.29% | 17.01% | 18.56% | 26.95% | 30.70% |
| Income Before Tax | -26.39% | 13.63% | 16.91% | 25.62% | 33.52% |
| Income Tax Expenses | 71.12% | 84.42% | 78.65% | 80.87% | 54.90% |
| Earnings from Continuing Operations | -32.46% | 7.89% | 10.51% | 19.31% | 31.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.46% | 7.89% | 10.51% | 19.31% | 31.50% |
| EBIT | 2.29% | 17.01% | 18.56% | 26.95% | 30.70% |
| EBITDA | 2.06% | 70.82% | 74.88% | 80.85% | 72.89% |
| EPS Basic | -30.91% | 8.79% | 11.33% | 20.05% | 32.15% |
| Normalized Basic EPS | 0.80% | 18.54% | 22.46% | 33.95% | 38.01% |
| EPS Diluted | -29.92% | 8.70% | 11.70% | 20.31% | 32.14% |
| Normalized Diluted EPS | 0.80% | 18.54% | 22.46% | 33.95% | 38.01% |
| Average Basic Shares Outstanding | 1.05% | 0.96% | 0.92% | 0.92% | 0.92% |
| Average Diluted Shares Outstanding | 1.05% | 0.96% | 0.92% | 0.92% | 0.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |